CareX SA
company
About
CareX SA is a biopharmaceutical company focused on metabolic disease.
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $32M
- Industries
- Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2001
- Operating Status
- Active
CareX SA is a biopharmaceutical company that develops novel treatments for metabolic and immune system disorders which includes diabetes and obesity. The company focuses on metabolic syndrome, a cluster of inter-related disorders of the body’s metabolism, including high blood pressure, high insulin levels, excess body weight, and abnormal cholesterol levels, that exposes individuals to the development of type 2 diabetes, heart diseases, and strokes.CareX SA is a France-based company that was founded in 2001 and the company was acquired by 7TM Pharma on May 24, 2006.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$32M
CareX SA has raised a total of
$32M
in funding over 2 rounds. Their latest funding was raised on
Mar 8, 2004 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 8, 2004 | Series B | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
CareX SA is funded by 1 investors.
Crédit Lyonnais Private Equity
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
